Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Open Label Safety Study of a Sublingual Specific Immunotherapy With a Solution of Birch Pollen Allergen Extract in Patients With Clinically Relevant Birch Pollen Allergy

NCT00818181 is registered in ClinicalTrials.gov with Allergopharma GmbH & Co. KG as lead sponsor.

NCT NCT00818181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00818181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Open Label Safety Study of a Sublingual Specific Immunotherapy With a Solution of Birch Pollen Allergen Extract in Patients With Clinically Relevant Birch Pollen Allergy
Lead sponsor
Allergopharma GmbH & Co. KG
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2008
Completion date
August 31, 2010
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rhinoconjunctivitis